Across TCGA pan-cancer cohorts, RPS17P8 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPS17P8’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPS17P8 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS17P8 is over-expressed in tumor.
KIRC, THCA, and PRAD are the cancer types where RPS17P8 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS17P8 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.